Factors accounting for the association between anxiety and depression, and eczema: the Hordaland health study (HUSK)

Table 3 Anxiety and depression as a function of eczema, with cumulative adjustments for possible contributing factors.

	Anxiety		Depression		Both
Cumulative adjustments	OR	95%CI	OR	95%CI	OR	95%CI
Total sample (N = 15715)
None	1.49*	1.35-1.64	1.25*	1.04-1.49	1.55*	1.36-1.76
Gender	1.45*	1.31-1.60	1.31*	1.09-1.56	1.55*	1.36-1.77
SES¹	1.43*	1.30-1.59	1.28*	1.07-1.53	1.52*	1.33-1.73
Occupation/Industry	1.43*	1.30-1.59	1.26*	1.05-1.51	1.50*	1.31-1.71
Omega-3 supplement	1.42*	1.29-1.58	1.26*	1.06-1.51	1.50*	1.31-1.71
Current smoking	1.43*	1.26-1.51	1.26*	1.05-1.51	1.50*	1.31-1.72
Subsample I (N = 7024)
None	1.45*	1.24-1.69	1.41*	1.10-1.81	1.60*	1.32-1.95
Gender and SES¹	1.40*	1.19-1.63	1.43*	1.11-1.84	1.56*	1.27-1.90
Fibromyalgia	1.37*	1.17-1.60	1.40*	1.08-1.80	1.51*	1.24-1.85
Other somatic diagnoses²	1.34*	1.15-1.57	1.40*	1.08-1.80	1.47*	1.20-1.80
Somatization³	1.15	0.98-1.35	1.27	0.98-1.64	1.21	0.97-1.50
Health anxiety	1.10	0.93-1.31	1.23	0.95-1.60	1.17	0.93-1.47
Adjusted for all factors above⁴	1.09	0.92-1.29	1.22	0.94-1.59	1.19	0.94-1.51
Female sub-sample (N = 8600)
None	1.40*	1.23-1.58	1.16	0.88-1.53	1.66*	1.39-1.98
SES¹	1.39*	1.22-1.57	1.14	0.86-1.51	1.64*	1.38-1.96
Hormonal contraceptives	1.39*	1.22-1.57	1.14	0.86-1.50	1.64*	1.38-1.96
HRT⁵	1.38*	1.22-1.57	1.14	0.86-1.50	1.63*	1.37-1.95
Parity	1.38*	1.22-1.56	1.14	0.86-1.50	1.62*	1.36-1.94

OR, odds ratio; CI, confidence interval;
*p < 0.05.
¹Educational level, marital status and income;
²Self-reported somatic diagnoses and medication for somatic conditions;
³ Somatic symptoms included in symptom criteria of the ICD-10 diagnosis F45.0 Somatization disorder (skin symptoms excluded);
⁴Including occupation/industry, omega-3 supplement and current smoking;
⁵Hormonal replacement therapy (Oestrogen tablets or Plaster).

ISSN: 1471-5945